Concepedia

Ned Adams

NA

Statistics

Publications

6

Citations

509

H-Index

6

Active since

1994

Affiliations

Gradalis (United States)(Current)

Mary Crowley Cancer Research Center

Texas Oncology

Medical City Dallas Hospital

Ned Adams is an author at Gradalis (United States) specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1994–2017

6

Publications

6

A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors

John Nemunaitis, Alex W. Tong, Michael Nemunaitis et al. · Molecular Therapy · 2009 · 267 citations · Full text

, , +13

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews et al. · Gynecologic Oncology · 2016 · 90 citations

, , +16

Characterization of a Novel Prostate-Specific Antigen–Activated Peptide-Doxorubicin Conjugate in Patients With Prostate Cancer

Robert S. DiPaola, John J. Rinehart, John Nemunaitis et al. · Journal of Clinical Oncology · 2002 · 83 citations

, , +17

Familial Sneddon's syndrome

A. D. Pettee, Bruce A. Wasserman, Ned Adams et al. · Neurology · 1994 · 41 citations

, , +13

Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy

Maurizio Ghisoli, McCarley Rutledge, Philip J. Stephens et al. · Journal of Pediatric Hematology/Oncology · 2017 · 16 citations

, , +17

1–5 of 6